Company:  ACASTI PHARMA INC. (ACST)
Form Type:  6-K
Filing Date:  7/17/2017 
CIK:  0001444192 
Address:  545 PROMENADE DU CENTROPOLIS
SUITE 100
 
City, State, Zip:  LAVAL,  H7T 0A3 
Telephone:  (450) 687-2262 
Fiscal Year:  03/31 
Last Trade
Last Trade: 
$1.30  
Change: 
-0.0761 (-5.52%)  
Trade Time: 
12:15 PM EST  
Market Cap: 
$19.18M
Trade ACST now with 

© 2017  
Description of Business
We were incorporated on February 1, 2002 under Part 1A of the Companies Act (Québec) under the name "9113-0310 Québec Inc." On February 14, 2011, the Business Corporations Act (Québec) came into effect and replaced the Companies Act (Québec). We are now governed by the Business Corporations Act (Québec). On August 7, 2008, under a Certificate of Amendment, we changed our name to "Acasti Pharma Inc.", our share capital description, the provisions regarding restrictions on transfers of our securities and our borrowing powers. On November 7, 2008, under a Certificate of Amendment, we changed the provisions regarding our borrowing powers. We became a reporting issuer in Québec on November 17, 2008. Our head and registered office is located at 545 Promenade du Centropolis, Suite 100, Laval, Québec H7T 0A3. We currently employ 15 full-time employees, with the majority working out of our headquarters in Laval and our laboratory in Sherbrooke, Québec.
Register and access this filing in:     
  FORM 6-K
    SIGNATURES
  EXHIBIT 99.1
  EXHIBIT 99.2
  EXHIBIT 99.3
  EXHIBIT 99.4